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Available online 8 April 2010I read with interest the paper by Leal et al.1 The technique
proposed [transcervical carotid stenting (TCS)þ carotid flow
reversal] was associated with a low incidence of new
ischemic brain lesions (12.5%) when checked by DW-MRI. The
aim of the study was to prove the safety of this hybrid
procedure (neck surgery þ CAS) in preventing stroke and
silent brain infarctions. We know that the real role of CAS is
still the subject of debate and no randomized trial has yet
proved the superiority of CAS over CEA.2
From this point of view the paper lacks a comparison
with CEA, which is the gold standard for carotid lesions. As
a second point, the device used to protect the brain in this
study may also be questionable. For best results, the
embolic protection device needs to be matched to each
patient and lesion: this means that there is no room for
standardization as the same device cannot be suitable for
all different patients and lesions. CAS could be considered
as an alternative to CEA and I strongly believe that there
are precise indications for such a hybrid technique. The
critical steps of CAS that are most likely to produce emboli
are during engagement of the CCA, advancement of the
guiding catheter or sheath into the CCA, crossing of the
stenotic lesion with the guide wire, stent deployment and
balloon dilatation. The hybrid procedure could reduce the
embolic load by removing one of these critical steps. As
reported by many other Authors, the crucial aspects of CAS
(as for every vascular intervention) are the inter-
ventionist’s/surgeon’s learning curve, combined with fullDOI of original article: 10.1016/j.ejvs.2010.02.006.
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restricted to subgroups of patients with a particularly
difficult arch anatomy or shaggy aorta, in order to
overcome possible preventable access problems.
Moreover, as the operator’s skill and materials improve,
the trans-femoral approach may be considered more
appropriate due to the mini-invasiveness of access (cut-
down vs. percutaneous approach), the duration of the
procedure, the LOS and possibly lower expense.
The clinical significance of new post-procedural silent
ischemic cerebral lesions is still unknown; the only certainty is
that todate,CEA is theprocedurewith the lowest embolic risk.
I wondered when I first read about this technique some
years ago, why I shouldn’t make a slightly longer incision
and perform a gold standard CEA.
Papers such as this by Leal et al.1 are essential to grad-
ually improve our knowledge of CAS, while the real role of
CAS needs to be investigated by the scientific world through
randomized studies, so the role of this hybrid procedure can
be tailored. The best technique must in any case be that
with the lowest risk of debris-related embolization.
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